NCT02933060View on ClinicalTrials.gov

Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

September 26, 2017

Study Completion Date

September 28, 2017

Conditions
Migraine Headache
Interventions
OTHER

Normal saline (1000 mL)

OTHER

Control

Trial Locations (1)

08103

Cooper Univeristy Hospital, Camden

All Listed Sponsors
lead

The Cooper Health System

OTHER

NCT02933060 - Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache | Biotech Hunter | Biotech Hunter